PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29061583-6	2018	In addition, recombinant NRF2-siRNA was effective to sensitize both 143B and MG63 cells to doxorubicin, cisplatin, and sorafenib, which was associated with significant downregulation of NRF2-targeted ATP-binding cassette (ABC) efflux transporters (ABCC3, ABCC4, and ABCG2).	Sorafenib	119-128	ATP binding cassette subfamily C member 3	Homo sapiens	248-253	
26769852-0	2016	MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma.	Sorafenib	38-47	ATP binding cassette subfamily C member 3	Homo sapiens	0-4	
26769852-8	2016	When MRP3 gene was knocked down by siRNA in PLC-PRF5-R2 cells, the sensitivity of the cells to sorafenib was restored.	Sorafenib	95-104	ATP binding cassette subfamily C member 3	Homo sapiens	5-9	
26769852-10	2016	Our data clearly demonstrate that the efflux transporter MRP3 plays an important role in resistance to sorafenib in HCC cells.	Sorafenib	103-112	ATP binding cassette subfamily C member 3	Homo sapiens	57-61	
33220273-7	2021	EX-527 reduced MRP3 and BCRP expression in sorafenib-treated HCC cells.	Sorafenib	43-52	ATP binding cassette subfamily C member 3	Homo sapiens	15-19	
33220273-8	2021	Since ABC transporters contribute to MDR, MRP3 and BCRP could be also influencing in the response of HCC cells to sorafenib.	Sorafenib	114-123	ATP binding cassette subfamily C member 3	Homo sapiens	42-46